Sponsored by BioLife Solutions
Organized by the ISCT Business Models and Cost of Goods Committee
Event Date: Wednesday, November 18, 2015
9am-10am Pacific; 12pm-1pm Eastern; 6pm-7pm CET (Europe)
John Fink, MBA, Product Marketing Manager, Brooks Life Science Systems, USA
Brian Murphy, PhD, Director, Bioprocess Development, Celgene, USA
Ian Pope, PhD, MBA, Senior Director, General Cryo Solutions, Brooks Life Science Systems, USA
Kevin O’Donnell, Vice President, Cold Chain Standards, Practices & Compliance, BioLife Solutions, USA
Cold chain logistics are an essential and expensive requirement of most cell therapy products in clinical development and for commercialization. An increasing trend in the cell therapy industry is that products will need to be shipped at cold to ultra-cold temperatures for longer distances and between countries. Whether you plan to commercialize directly, or license to a commercial partner, optimizing your cold chain requirements and logistics costs during development can be an important factor in determining the ultimate pricing and profitability of your product. In this session, speakers from BioLife, Celgene and Brooks will help to increase your knowledge of product development decisions that can influence your cold chain logistics requirements and also practical considerations for optimizing your cold chain distribution costs, while still meeting quality and regulatory requirements.
This webinar is free as part of the ISCT Corporate Sponsored Webinar Program.
Registration Deadline: Tuesday November 17, 2015 (midnight, PT)